Article
Author: García-Castillo, María ; Cercenado, Emilia ; Pitart, Cristina ; Pinto, Margarida F. ; Tormo, Nuria ; Sancho, Luísa ; Alves, Valquíria ; Duarte, Joana ; Hernández-García, Marta ; Pássaro, Leonor ; Chaves, Catarina ; Cruz, Hugo ; Bou, Germán ; Díaz-Regañón, Jazmín ; Diogo, José ; Gonçalves, Elsa ; Oliver, Antonio ; Cantón, Rafael ; Ferreira, Rui ; Rodríguez-Lozano, Jesús ; Vieira, Ana Raquel ; Delgado-Valverde, Mercedes ; Melo-Cristino, José ; Ramalheira, Elmano
We comparatively evaluate the
in vitro
activity of a drug combination consisting of a carbapenem (imipenem) and a novel inhibitor of beta-lactamases (relebactam), a mechanism that destroys beta-lactam antibiotics. We assess the activity against a collection of
Enterobacterales
clinical isolates recovered from difficult-to-treat infections in patients admitted to different intensive care units in Portugal and Spain.